Investor Relations

Welcome to the Investor Relations for Phase Holographic Imaging (PHI)

What’s New

Press Releases

October 4, 2024

Phase Holographic Imaging PHI AB receives approx. SEK 5.2 million through warrant exercise

On 3 October 2024, the exercise period for warrants of series TO 4, which were issued in connection with Phase Holographic Imaging PHI AB’s (“PHI” or the “Company”) rights issue of units in 2022 (“TO 4”), ended. In total, 1,129,513 warrants of series TO 4 were exercised, corresponding to a subscription rate of approximately 83.9 percent. PHI is thus provided approximately SEK 5.2 million before deduction of transaction related costs.

1…678910…134

News featuring PHI

May 23, 2024

BioStock: PHI “It’s the right moment to capitalize on regenerative medicine momentum.”

BioStock contacted CEO Patrik Eschricht for an update on the company’s progress and how PHI will capitalize on the current momentum.

1…678910…30

About PHI

Phase Holographic Imaging (PHI) develops and markets its non-invasive time-lapse imaging instruments. The company’s current HoloMonitor® products are globally used for long-term quantitative analysis of living cell cultures, particularly in preclinical research.

Now, PHI is actively focusing on business development. With unique solutions focused on Quantitative Phase Imaging (QPI) — a technology that brings a novel, cell-friendly approach to critical cell quality evaluation, PHI is expanding into the fast-growing regenerative medicine field.

PHI envisions transforming live cell analysis and establishing its QPI technology as a standard for cell quality control, making our future cell therapies safe, affordable, and accessible for patients. PHI is based in Lund, Sweden, Boston, MA and Winston-Salem, NC.

Investor Information

All Press Releases

Here you can read all PHI press releases.

Read Press Releases

Company News

Here you see PHI featured in news and CEO commentaries.

See Company News

Reports & Documents

Here you find PHI’s interim and annual reports, as well as view general meeting and emission documents.

Find Reports & Documents

Investor Q&A

Here you can browse the frequently asked investor questions and quickly find your answers.

Browse Investor Q&A

Any questions? Please get in touch with our CEO,
Anders Månsson, at: ir@phiab.com

Investor Calendar

Stock Information